INTRODUCTION AND OBJECTIVES: Bladder smooth muscle (BSM) caveolae are cholesterol-enriched membrane microdomains that augment or attenuate detrusor functional responses by differentially regulating specific receptor-activated signaling pathways. However, BSM contractions induced by cholinergic activation in the rat are not altered by depletion of caveolae, unlike other smooth muscle systems in which muscarinic receptor signaling is evidently mediated by caveolae. Although this discrepancy may reflect the highly specific regulation imparted by caveolae among different tissues and species, a differential regulation of muscarinic M 3 and M 2 receptor subtypes in the bladder cannot be excluded. This study examined the functional and molecular relationship between caveolae and muscarinic acetylcholine receptor (mAChR) subtypes M 3 and M 2 .
INTRODUCTION AND OBJECTIVES: Diabetes type-2 accounts for almost 90% of diabetes cases worldwide. Diabetes among other complications induces bladder dysfunction. In the current study we aimed to create a short-period diabetes type-2 model in order to investigate oxidative stress-related alterations in the bladder in the initiation of the disease. Additionally antioxidant treatment with resveratrol or taurine was provided in order to examine whether it is possible to prevent these alterations in the very beginning of the disease.
METHODS: Diabetes was induced in 8-week-old male Wistar rats with a single dose of streptozotocin (40mg/kg) intraperitoneally (i.p.). The next day they were randomly separated into 3 groups and 14 days feeding with a high fat diet followed. One group received no treatment (DM group), another group received orally resveratrol (10mg/ Kg; Resv group) and the third one received taurine i.p. (1g/Kg; Tau group). Age matched control animals were used and were fed with normal diet (Control group). Two weeks later animals were sacrificed and bladder were processed for histological evaluation, measurements of malondialdehyde (MDA) and immunohistochemistry (IHC) for oxidative stress markers.
RESULTS: At the end of 2 weeks all diabetic groups had significantly lower body weight compared to the Control group. DM group demonstrated significantly higher ratio of bladder weight to body weight compared to the Control (Figure 1 ). Histological evaluation demonstrated mild damage of the bladder tissue in the DM group such as abruption of the mucosa from the muscularis as well as edema in the transitional epithelium. All these alterations were not observed in the treatment groups. MDA levels in the bladder were significantly larger in the DM group compared with Control, Resv or Tau group (Figure 1 ). Fourteen days of diabetes without treatment in the DM group induced moderate to strong intensity and positivity for oxidative stress marker MDA, 4-Hydroxynonenal and DNA oxidative stress marker 8-deoxyguanosine compared with the other three groups.
CONCLUSIONS: The prompt diagnosis of diabetes can be crucial for the progression of the disease. Specifically in the bladder, it appears that both mild damage in structural level as well as oxidative damage in molecular level can be prevented by resveratrol or taurine treatment.
Source of Funding: None

MP94-17 DYNAMIC IMAGING OF URINE FLOW AT BLADDER NECK IN RABITT DURING VOIDING USING TRACER BY WIRELESS CAPSULE ENDOSCOPE
Tokunori Yamamoto*, Hideki Mizuno, Nagoya, Japan; Shigehiro Soh, Koshigaya, Japan; Yasuhito Funahashi, Yoshihisa Matsukawa, Masanao Nakamura, Momokazu Gotoh, Nagoya, Japan INTRODUCTION AND OBJECTIVES: There was not yet report on visualizing flow at voiding from baldder neck in vivo. We vizualized e1252
THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Tuesday, May 16, 2017 urine flow from internal vew of baldder neck. using by wireless capsule endoscopes (WCEs) for cystoscopy at voiding in vivo. METHODS: Experimental evaluation of capsule cystoscopy was performed in a 5-kg farm rabbits(n¼6). The capsule was inserted after incision of bladder. Images were continuously transmitted at a rate of four frames per second to a laptop computer and processed using proprietary software. Manipulation of the WCE within the bladder was performed using a set protocol. We measured the ability to deploy and manipulate the capsule within the bladder. Feasibility of capturing and retrieving images in real time was also assessed. We used air bubble(injection by syringe) and dye(intravenous administration of indigocarmine) as urine flow tracer.
RESULTS: The WCE was efficiently deployed and manipulated within the bladder passively by manual. The entire bladder mucosa realtime image transmission and capture was visualized. The urine flow rotated clockwise from ventral to visceral at bladder neck during voiding. CONCLUSIONS: By this device, urine flow could be visualized a vortex with rotation clockwise from ventral to visceral at the bladder neck mucosa during voiding.
Source of Funding: none
MP94-18 UROTHELIAL CELLS EXPRESS A FUNCTIONAL SUCCINATE RECEPTOR GPR91
Abubakr Mossa, Monica Velasquez-Flores, Philippe Cammisotto, Lysanne Campeau*, Montreal, Canada INTRODUCTION AND OBJECTIVES: Overactive bladder is associated with the metabolic syndrome. Increased succinate production is detected in the presence of hyperglycemia and hypoxemia, as with diabetes mellitus and metabolic syndrome. Succinate was recently identified as a major metabolic switch controlling metabolic functions in the body through its receptor GPR91 (SUCNR1). The aim of our study is to determine how succinate interacts with urothelial cells through its receptor.
METHODS: Urothelial cells were isolated from female Sprague-Dawley rat bladder using a collagenase IV method. After confluency, cells were exposed to succinate then treated for microscopy and immunoblotting. Cyclic AMP and PGE 2 were measured using an Elisa kit from Cayman Chemical Company. Nitric oxide was assessed by an colorimetric method. Retroviruses were generated for shRNA-mediated knockdown of GPR91.
RESULTS: Urothelial cells were characterized using Cytokeratin 17 and the AE1/AE3 antibody. RT-PCR confirmed expression of GPR91. Short-term incubation of cells with succinate (200 mM) results in phosphorylation of Erk and c-Jun amino-terminal kinases (JNKs). Inhibition of the MAPK pathway by PD98059 (10 mM) inhibited increases of Erk-P elicited by succinic acid. On the other hand, pre-incubation of cells with succinate dose-dependently decreased the concentrations of intracellular cyclic AMP stimulated by forskolin. Succinate triggers entry of calcium inside urothelial cells as visualized by confocal microscopy. Long-term incubation of cells with succinate increased secretion of nitric oxide and decreased PGE 2 release. Cells infected with shRNA retrovirus targeting GPR91 displayed a strong decrease in GPR91 expression. This was associated with a loss of succinate-stimulated Erk phosphorylation. Moreover, inhibition of cyclic AMP synthesis, increases in intracellular calcium and release of nitric oxide were all dramatically prevented.
CONCLUSIONS: GPR91 is expressed in urothelial cells. Binding of succinate to its receptor triggers phosphorylation of Erk and JNK, a process that requires the MAPK pathway. Inhibition of cyclic AMP production suggests the receptor is bound to protein G i . Release of nitric oxide and decrease of PGE 2 are under succinic acid control suggesting a potential cross-talk between urothelium and detrusor muscle.
Source of Funding: FRQS
MP94-19 A POTENTIAL NOVEL MECHANISM FOR DETRUSOR UNDER-ACTIVITY MEDIATED BY MYOSIN LIGHT CHAIN PHOSPHORYLATION AND AMP-DEPENDENT KINASE
Randy Vince*, Ramanan Remesh, John Speich, Adam Klausner, Amy Miner, Paul Ratz, Richmond, VA INTRODUCTION AND OBJECTIVES: Muscarinic receptor stimuli such as carbachol (CCh) cause increases in detrusor smooth muscle (DSM) myosin light chain (MLC) phosphorylation and contraction. Notably, upon stimulation with CCh, DSM force rises rapidly to a peak value, then gradually declines (fades) despite the continued presence of CCh. The mechanism behind the fade in force s not understood. There is evidence that, in addition to causing contraction, muscarinic receptor stimulation can activate AMPK, and AMPK has been shown to negatively regulate smooth muscle contraction. The purpose of this study was to test the hypothesis that DSM contraction fade is due to the delayed activation of AMPK.
METHODS: Mouse bladder with mucosa were cut into rings~3 mm wide, and strips of DSM free from underlying mucosa were removed from rabbit bladders. Each tissue was placed in an organ bath connected to a force transducer and length-adjuster and subjected to a length-tension protocol to identify the length (Lref) that produced the strongest active force induced by KCl. Each ring was subsequently set to 95% Lref. Three tissues were then contracted by exposure to 10 microM CCh and quick-frozen at 5, 30 and 180 seconds. A fourth tissue was not contracted and quick-frozen to assess the basal-state. Tissues were subsequently processed to quantify the level of phosphoproteins that are indices of activation of AMPK (ACC-pS79 and AMPK-p172) and of actomyosin crossbridges (MLC-pS19 and MYPT1-pT853).
RESULTS: Compared to the basal-state, CCh induced a strong increase in force in mouse bladder and rabbit DSM that peaked at, respectively, 60 sec and 20 sec, before declining to~50% of the peak values within 180 sec (n¼3). MLC-p also displayed a biphasic response. AMPK-pand ACC-p displayed a delayed increase corresponding with the decrease in contractile force.
CONCLUSIONS: Muscarinic receptor stimulus CCh caused a rapid increase in force in mouse bladder and rabbit DSM that faded with time despite the presence of CCh. This fade in force correlated with a delayed increase in AMPK activity as assessed by increases in the phosphoproteins, ACC-p and AMPK-p. Because AMPK has been shown to inhibit smooth muscle contraction, the correlation of an increase in AMPK activity with the decrease in force supports the hypothesis that AMPK may be responsible for fade in DSM force. Because AMPK activity is also elevated during ischemia/hypoxia, a condition
